Human Phospho-EGFR (Y1068) Antibody MAB3570 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemHuman Phospho-EGFR (Y1068) Antibody
CompanyR&D Systems, a Bio-Techne Brand
Price $449.00Supplier Page View Company Product Page
Catalog NumberMAB3570
Quantity100 ug (also 25 ug)
ApplicationsWestern Blot,Intracellular Staining by Flow Cytometry,Immunocytochemistry,CyTOF-ready
Conjugate/TagUnconjugated
FormatLyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS
ConcentrationLYOPH
PurityProtein A or G purified from hybridoma culture supernatant
IsotypeIgG2a
Clone338324
HostMouse
ReactivityHuman
TargetEGFR
Modificationsp tyr1068
Antibody TypePrimary Antibodies
ClonalityMonoclonal
ImmunogenPhosphopeptide containing human EGFR Y1068 site
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution
NCBI Full Gene Nameepidermal growth factor receptor
NCBI Gene AliasesERBB, ERBB1, ERRP, HER1, NISBD2, PIG61, mENA

Specifications/Features

Available conjugates: Unconjugated

Add to Compare List

R&D Systems, a Bio-Techne Brand

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

Company Profile

Website: http://www.rndsystems.com

(1) Chemical probe mediated visualization of protein S-palmitoylation in patient tissue samplesFrontiers in physiologyJanuary 1, 2023Schek N, Lee JY, Burslem GM, Witze E.37°C. Incubation with primary antibodies specific for phosphorylated EGFR (Y1068) (Novus Biologicals #MAB3570) and for fluorescein/OG 488 (Life Technologies A-889) was done overnight at 4°C. The Duolink assay was

(2) BEBT-109, a pan-mutant-selective EGFR inhibitor with potent antitumor activity in EGFR-mutant non-small cell lung cancerTranslational oncologyFebruary 1, 2021Fan F, Zhou M, Ye X, Mo Z, Ma Y, Luo L, Liang X, Liu H, Weng Y, Lin M, et al.

(3) Mechanism of intrinsic resistance of lung squamous cell carcinoma to epithelial growth factor receptor-tyrosine kinase inhibitors revealed by high-throughput RNA interference screeningOncology lettersDecember 1, 2020Ju L, Dong Z, Yang J, Li M.

(4) Counting growth factors in single cells with infrared quantum dots to measure discrete stimulation distributionsNature communicationsFebruary 22, 2019Le P, Lim SJ, Baculis BC, Chung HJ, Kilian KA, Smith AM.

(5) Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infectionPloS oneJanuary 1, 2018Basova L, Najera JA, Bortell N, Wang D, Moya R, Lindsey A, Semenova S, Ellis RJ, Marcondes MCG.

(6) GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activityOncotargetNovember 29, 2016Lindberg OR, McKinney A, Engler JR, Koshkakaryan G, Gong H, Robinson AE, Ewald AJ, Huillard E, David James C, Molinaro AM, et al.used Antibody Manufacturer Clone Catalog no Application Concentration Ms α Phospho EGFR Y1068 R&D Systems 338324 MAB3570 WB 1:500 Rb α Phospho EGFR Y1173 Cell Signaling 53A5 4407 WB 1:500 Rb α Phospho Stat3 Y705 Cell Signaling

(7) Activation of EGFR by small compounds through coupling the generation of hydrogen peroxide to stable dimerization of Cu/Zn SOD1Scientific reportsFebruary 17, 2016Sakanyan V, Hulin P, Alves de Sousa R, Silva VA, Hambardzumyan A, Nedellec S, Tomasoni C, Logé C, Pineau C, Roussakis C, et al.

(8) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancerCancer discoverySeptember 1, 2014Cross DA, Ashton SE, Ghiorghiu S, Eberlein C, Nebhan CA, Spitzler PJ, Orme JP, Finlay MR, Ward RA, Mellor MJ, et al.membranes were blotted with total EGFR (BD Biosciences, #610017), phospho-EGFR (Tyr1068, R&D Systems, MAB3570 or Tyr1173, Santa Cruz Technologies, Inc, sc-12351), total AKT (Cell Signaling, 9272S), phospho-AKT

(9) S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinomaGene therapyOctober 1, 2012Lee K, Yun ST, Yun CO, Ahn BY, Jo EC.

Be the First to Write a Review!

Phospho-EGFR (Y1068) Antibody

Phospho-EGFR (Y1068) Antibody

Phospho-EGFR (Y1068) Antibody

Human Phospho-EGFR (Y1068) Antibody from R&D Systems, a Bio-Techne Brand

Specifications/Features

R&D Systems, a Bio-Techne Brand

Citations (9)

Reviews

Human Phospho-EGFR (Y1068) Antibody from R&D Systems, a Bio-Techne Brand

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map